IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test

OBJECTIVE: IDegLira is a novel, fixed-ratio combination of the long-acting basal insulin, insulin degludec, and the long-acting glucagon-like peptide-1 analog liraglutide. We studied the effect of IDegLira versus its components on postprandial glucose (PPG) in type 2 diabetes. METHODS: In this subst...

Descripción completa

Detalles Bibliográficos
Autores principales: Holst, Jens J., Buse, John B., Rodbard, Helena W., Linjawi, Sultan, Woo, Vincent C., Boesgaard, Trine Welløv, Kvist, Kajsa, Gough, Stephen C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773967/
https://www.ncbi.nlm.nih.gov/pubmed/26443290
http://dx.doi.org/10.1177/1932296815610124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773967/
https://www.ncbi.nlm.nih.gov/pubmed/26443290
http://dx.doi.org/10.1177/1932296815610124

Ejemplares similares